Meanwhile, silencing TROP2 expression in cervical cancer cells suppresses the proliferation and invasion, also sensitizes cells to cisplatin and induces cell cycle arrest by suppression of ERK1/2 signaling pathway. Here, TACSTD2 is linked to cervical cancer.